Regenerys Ltd. develops and sells regenerative medicine products focused on bioprocessing and biostorage. The company offers Myskin, a treatment for serious burns and hard-to-heal wounds that utilizes cultured autologous cells from the patient's own skin, and Cryoskin, which also employs autologous cells for burn treatment. Additionally, Regenerys provides Adiposet, a service designed to enhance cosmetic outcomes in breast cancer surgery and other procedures by allowing the storage and return of adipose tissue for lipomodellin. The firm also delivers third-party bioprocessing and biostorage services through its laboratories. Regenerys serves both NHS and private healthcare providers across the United Kingdom and Europe. Established in 2011, it is headquartered in Cambridge, United Kingdom.
Xerion Healthcare Limited is a UK-based company focused on developing and commercializing nanoparticle treatments to enhance the effectiveness of cancer therapies, specifically targeting head, neck, and pancreatic tumors. Founded in 2015, the company utilizes titanium dioxide nanoparticles, a non-toxic semiconductor material, which are injected into tumors prior to standard radiotherapy. This innovative approach amplifies the dose of free radicals produced by X-rays, thereby improving the treatment's efficacy while minimizing potential side effects. By integrating this nanomedicine technology into conventional radiotherapy, Xerion Healthcare aims to provide more effective solutions for patients with challenging cancer types.
Spectromics develops a diagnostic system that helps to guide antibiotic treatment. It provides a point-of-prescription test for bacterial infections that guides the treatment of antibiotics.
Spectromics began operation in 2014. Its headquarters is in Manchester in the United Kingdom.
Surface Generation is a privately-owned high technology and manufacturing company headquartered in the UK and with facilities in North America and Asia. Its patented Production to Functional Specification (PtFS) technology enables manufacturers in the aerospace, automotive and consumer electronics sectors to work with composite materials, saving costs, energy and producing significantly lighter weight products.
Atto is a company that specializes in online identity verification services, focusing on identity proofing and verification through its IDaaS platform. This platform facilitates the brokering of verified personal attributes and multi-factor authentication, aiding various sectors such as healthcare, recruitment, gaming, retail banking, and consumer finance. Atto's solutions enhance customer onboarding processes by addressing challenges related to risk management, compliance, and fraud, while also enabling businesses to assess customer affordability and verify account information. The company connects to over 5,500 banks across 30 countries, supporting Open Banking initiatives. With a growing client base and recent collaborations with major financial institutions, Atto aims to streamline the application process for lenders and other businesses, ultimately improving customer experience. Founded in 2010 and based in Edinburgh, Atto also maintains offices in New York, London, and Sydney.
Nanna Therapeutics is a drug discovery company addressing age-related diseases for which others are failing to provide effective treatments. These include mitochondrial, neurodegenerative, cardiovascular or metabolic, joint or tissue disease as well as cancer. Nanna Therapeutics are targeting fundamental cellular processes to create drugs to treat age-related diseases and improve longevity. Such drugs include those to combat debilitating neurodegenerative, inflammatory, cardiovascular and metabolic diseases as well as many cancers. With a strong focus on mitochondria, the energy source in every cell, we can target the fundamental causes of many age-related diseases. Through this approach we can also address debilitating, life-limiting mitochondrial diseases for which there are currently few effective therapies. Nanna Therapeutics has developed a tightly integrated set of proprietary technologies that radically disrupt current methods of creating new medicines. This Totally Integrated Medicines Engine (TIME) has been devised to answer the needs of drug discovery and development scientists utilising the best in 21st century technologies of microfluidics, nanofabrication and artificial intelligence.
Endomag is a medical technology company devoted to improving the global standard of cancer care. The company's Sentimag probe, Magseed marker, and Magtrac node marker are already in use by many of the world’s leading physicians and cancer centers. Endomag's goal is to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. As of 2019, the company has already helped 70,000+ women around the world access more precise and less invasive breast cancer care. Founded in 2007 as a spin-out from the University of Houston and the University College London (UCL), Endomag continues to develop its unique clinical platform from its headquarters in Cambridge, United Kingdom. The company sells its products through a network of distributors in Europe, the Middle East, Africa, and Australasia.
Atto is a company that specializes in online identity verification services, focusing on identity proofing and verification through its IDaaS platform. This platform facilitates the brokering of verified personal attributes and multi-factor authentication, aiding various sectors such as healthcare, recruitment, gaming, retail banking, and consumer finance. Atto's solutions enhance customer onboarding processes by addressing challenges related to risk management, compliance, and fraud, while also enabling businesses to assess customer affordability and verify account information. The company connects to over 5,500 banks across 30 countries, supporting Open Banking initiatives. With a growing client base and recent collaborations with major financial institutions, Atto aims to streamline the application process for lenders and other businesses, ultimately improving customer experience. Founded in 2010 and based in Edinburgh, Atto also maintains offices in New York, London, and Sydney.
SPARKL Limited, founded in 2012 and based in London, United Kingdom, specializes in transaction router solutions that enhance business-level transactions through service level agreements. The company's primary product, the SPARKL Sequencing Engine, allows users to manage the behavior of distributed machines, systems, and applications. Utilizing a straightforward, declarative configuration known as Clear Box, the engine facilitates intelligent integration among various components while generating a tamper-proof audit trail to ensure regulatory compliance and optimize system performance. SPARKL collaborates with notable partners such as Cisco and Intel to expand its market reach and deliver its innovative solutions to a global audience.
Endomag is a medical technology company devoted to improving the global standard of cancer care. The company's Sentimag probe, Magseed marker, and Magtrac node marker are already in use by many of the world’s leading physicians and cancer centers. Endomag's goal is to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. As of 2019, the company has already helped 70,000+ women around the world access more precise and less invasive breast cancer care. Founded in 2007 as a spin-out from the University of Houston and the University College London (UCL), Endomag continues to develop its unique clinical platform from its headquarters in Cambridge, United Kingdom. The company sells its products through a network of distributors in Europe, the Middle East, Africa, and Australasia.
Atto is a company that specializes in online identity verification services, focusing on identity proofing and verification through its IDaaS platform. This platform facilitates the brokering of verified personal attributes and multi-factor authentication, aiding various sectors such as healthcare, recruitment, gaming, retail banking, and consumer finance. Atto's solutions enhance customer onboarding processes by addressing challenges related to risk management, compliance, and fraud, while also enabling businesses to assess customer affordability and verify account information. The company connects to over 5,500 banks across 30 countries, supporting Open Banking initiatives. With a growing client base and recent collaborations with major financial institutions, Atto aims to streamline the application process for lenders and other businesses, ultimately improving customer experience. Founded in 2010 and based in Edinburgh, Atto also maintains offices in New York, London, and Sydney.
Tapit Media Pty Ltd. specializes in developing a contactless management platform tailored for the outdoor, retail, and government sectors. Established in 2011 and headquartered in Sydney, Australia, with additional offices in New York and Toronto, Tapit offers a suite of contactless technologies, including Near Field Communication (NFC) and Beacons. These technologies enable clients to create, deliver, manage, and analyze real-time interactions across their Tapit-enabled infrastructure. The company has collaborated with prominent global brands such as Google, Microsoft, Samsung, and Visa to implement and oversee their contactless communication frameworks, which encompass NFC tags, Beacons, and QR codes. By utilizing Tapit's solutions, companies can engage consumers seamlessly and securely through their smartphones in physical environments like outdoor media and retail spaces.
Atto is a company that specializes in online identity verification services, focusing on identity proofing and verification through its IDaaS platform. This platform facilitates the brokering of verified personal attributes and multi-factor authentication, aiding various sectors such as healthcare, recruitment, gaming, retail banking, and consumer finance. Atto's solutions enhance customer onboarding processes by addressing challenges related to risk management, compliance, and fraud, while also enabling businesses to assess customer affordability and verify account information. The company connects to over 5,500 banks across 30 countries, supporting Open Banking initiatives. With a growing client base and recent collaborations with major financial institutions, Atto aims to streamline the application process for lenders and other businesses, ultimately improving customer experience. Founded in 2010 and based in Edinburgh, Atto also maintains offices in New York, London, and Sydney.
Atto is a company that specializes in online identity verification services, focusing on identity proofing and verification through its IDaaS platform. This platform facilitates the brokering of verified personal attributes and multi-factor authentication, aiding various sectors such as healthcare, recruitment, gaming, retail banking, and consumer finance. Atto's solutions enhance customer onboarding processes by addressing challenges related to risk management, compliance, and fraud, while also enabling businesses to assess customer affordability and verify account information. The company connects to over 5,500 banks across 30 countries, supporting Open Banking initiatives. With a growing client base and recent collaborations with major financial institutions, Atto aims to streamline the application process for lenders and other businesses, ultimately improving customer experience. Founded in 2010 and based in Edinburgh, Atto also maintains offices in New York, London, and Sydney.
Surrey NanoSystems Limited is a manufacturer of nanoscale materials, specializing in advanced super-black coatings, notably Vantablack. This innovative coating is applied to surfaces using vacuum-deposition technology, as well as through spraying and post-processing methods. Vantablack is utilized in a diverse array of applications, including stray light suppression, architectural lighting, sensors, telescopes, infrared imaging systems, and cinematography optics. Additionally, the coating enhances the performance of sensitive electro-optical imaging systems, making it valuable in sectors such as aerospace, automotive safety, architecture, and luxury goods. Founded in 2006 and headquartered in Newhaven, United Kingdom, Surrey NanoSystems was previously known as CEVP Limited before adopting its current name in December 2006.
Netmania Solutions, formerly known as Enhanced Telecommunications Ltd, specializes in device management solutions and has been involved in TR-069 delivery since 2001. The company provides software and hardware services tailored for various industries, including Internet service providers, cable operators, education, healthcare, and enterprise organizations. Netmania focuses on enhancing the customer journey, reducing churn, and improving profitability for its clients. Additionally, the company offers comprehensive software development services, including product development, data migration, and online systems, catering to both large enterprises and small to medium-sized businesses.
Endomag is a medical technology company devoted to improving the global standard of cancer care. The company's Sentimag probe, Magseed marker, and Magtrac node marker are already in use by many of the world’s leading physicians and cancer centers. Endomag's goal is to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. As of 2019, the company has already helped 70,000+ women around the world access more precise and less invasive breast cancer care. Founded in 2007 as a spin-out from the University of Houston and the University College London (UCL), Endomag continues to develop its unique clinical platform from its headquarters in Cambridge, United Kingdom. The company sells its products through a network of distributors in Europe, the Middle East, Africa, and Australasia.
Orthogem Limited specializes in developing and manufacturing synthetic bone grafts, utilizing its patented Tripore technology platform. This innovative platform has led to a diverse range of synthetic bone grafts (SBGs) designed for various clinical applications, including spinal and oral craniofacial surgeries. Orthogem's product offerings include TriPore Granules, TriPore MPA, and TriPore Blocks. Established in 2001 and headquartered in Nottingham, United Kingdom, the company focuses on achieving optimal bone remodeling through the osteoconductive and bioactive properties of its materials. These grafts are applicable for treating a wide array of conditions, including fractures, congenital disorders, traumatic injuries, and bone cancer, thereby providing reliable solutions for patients undergoing procedures such as lumbar spine fusion.
Aeristech Limited, founded in 2006 and based in Kenilworth, United Kingdom, specializes in developing electric air compressors for the automotive industry. The company manufactures a range of products, including electric superchargers and full electric turbochargers, which enhance engine efficiency and support engine downsizing. Aeristech also produces fuel cell air compressors designed to maintain consistent air pressure despite fluctuations in airflow or input voltage. In addition to its automotive focus, the firm serves industrial applications by providing components such as motor accelerators and hydrogen fuel compressors, which facilitate effective fuel combustion at low rates. The company operates as an engineering research and development consultancy, aiming to innovate in hybrid turbo technology and support advancements in battery electric vehicle cooling systems.